Literature DB >> 10700713

The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence.

S Fazio1, E A Palmieri, B Biondi, A Cittadini, L Saccà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10700713     DOI： 10.1530/eje.0.1420211

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  14 in total

1.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.

Authors:  Victoria Florea; Sonia S Majid; Rosemeire M Kanashiro-Takeuchi; Ren-Zhi Cai; Norman L Block; Andrew V Schally; Joshua M Hare; Claudia O Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 2.  Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.

Authors:  Nirat Beohar; Jonathan Rapp; Sanjay Pandya; Douglas W Losordo
Journal:  J Am Coll Cardiol       Date:  2010-10-12       Impact factor: 24.094

Review 3.  Protein therapeutics for cardiac regeneration after myocardial infarction.

Authors:  Vincent F M Segers; Richard T Lee
Journal:  J Cardiovasc Transl Res       Date:  2010-07-07       Impact factor: 4.132

Review 4.  Growth factors, nutrient signaling, and cardiovascular aging.

Authors:  Luigi Fontana; Manlio Vinciguerra; Valter D Longo
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

5.  Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.

Authors:  Rosemeire M Kanashiro-Takeuchi; Konstantinos Tziomalos; Lauro M Takeuchi; Adriana V Treuer; Guillaume Lamirault; Raul Dulce; Michael Hurtado; Yun Song; Norman L Block; Ferenc Rick; Anna Klukovits; Qinghua Hu; Jozsef L Varga; Andrew V Schally; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

6.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

7.  Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy.

Authors:  Lisa M Freeman; John E Rush; Kathryn M Meurs; Barret J Bulmer; Suzanne M Cunningham
Journal:  J Feline Med Surg       Date:  2012-09-21       Impact factor: 2.015

8.  Effects of tanshinone VI on insulin-like growth factor-1-induced hypertrophy of isolated cardiomyocytes from neonatal rats.

Authors:  Yuji Kawahara; Kouichi Tanonaka; Toru Arino; Toshiyuki Maki; Naoko Ishihara; Norio Takagi; Akira Yagi; Satoshi Takeo
Journal:  Exp Clin Cardiol       Date:  2004

9.  Low-dose growth hormone is cardioprotective in uremia.

Authors:  Ralph Rabkin; Ibrahim Awwad; Yu Chen; Euan A Ashley; Difei Sun; Sumita Sood; William Clusin; Paul Heidenreich; Grzegorz Piecha; Marie-Luise Gross
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

10.  Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.

Authors:  Emmanuelle Kuhn; Luigi Maione; Amir Bouchachi; Myriam Rozière; Sylvie Salenave; Sylvie Brailly-Tabard; Jacques Young; Peter Kamenicky; Patrick Assayag; Philippe Chanson
Journal:  Eur J Endocrinol       Date:  2015-11       Impact factor: 6.664
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.